Scopia Capital to inject up to $60mn into struggling R&Q

London-listed R&Q has hailed a deal with one of its new shareholders to inject $50mn+ into the business as a significant step in splitting its struggling legacy arm from its fast-growing MGA fronting business Accredited.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Spencer Halladey

Commercial director

+44 (0) 77 4160 9085

spencer.halladey@thomsonreuters.com

    Andy Stone

    Sales manager

    +44 (0) 77 4160 9204

    andy.stone@thomsonreuters.com